184 related articles for article (PubMed ID: 10422292)
21. Detection of ETV6/MDS1/Evi-1 chimeric transcripts in a patient with acute myelocytic leukemia and t(3;12)(q26;p13).
Nishimura Y; Wada H; Mori A; Takatsuka H; Tamura A; Fujimori Y; Okamoto T; Takemoto Y; Kakishita E
Int J Hematol; 2000 Jul; 72(1):108-9. PubMed ID: 10979219
[No Abstract] [Full Text] [Related]
22. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
[TBL] [Abstract][Full Text] [Related]
23. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.
Mitani K; Ogawa S; Tanaka T; Miyoshi H; Kurokawa M; Mano H; Yazaki Y; Ohki M; Hirai H
EMBO J; 1994 Feb; 13(3):504-10. PubMed ID: 8313895
[TBL] [Abstract][Full Text] [Related]
24. Translocation (3;21)(q26;q22) in secondary leukemia. Report of two cases and literature review.
Schneider NR; Bowman WP; Frenkel EP
Ann Genet; 1991; 34(3-4):256-63. PubMed ID: 1809236
[TBL] [Abstract][Full Text] [Related]
25. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia.
Farra C; Awwad J; Valent A; Lozach F; Bernheim A
Cancer Genet Cytogenet; 2004 Dec; 155(2):138-42. PubMed ID: 15571799
[TBL] [Abstract][Full Text] [Related]
26. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
Sakai I; Tamura T; Narumi H; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
Genes Chromosomes Cancer; 2005 Nov; 44(3):265-70. PubMed ID: 16015645
[TBL] [Abstract][Full Text] [Related]
27. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
[TBL] [Abstract][Full Text] [Related]
28. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1.
Sood R; Talwar-Trikha A; Chakrabarti SR; Nucifora G
Leukemia; 1999 Mar; 13(3):348-57. PubMed ID: 10086725
[TBL] [Abstract][Full Text] [Related]
29. Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML.
Cuenco GM; Nucifora G; Ren R
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1760-5. PubMed ID: 10677531
[TBL] [Abstract][Full Text] [Related]
30. Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
Deluche L; Joha S; Corm S; Daudignon A; Geffroy S; Quief S; Villenet C; Kerckaert JP; Laï JL; Preudhomme C; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Dec; 47(12):1110-7. PubMed ID: 18767145
[TBL] [Abstract][Full Text] [Related]
31. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
Chinen Y; Taki T; Nishida K; Shimizu D; Okuda T; Yoshida N; Kobayashi C; Koike K; Tsuchida M; Hayashi Y; Taniwaki M
Oncogene; 2008 Apr; 27(15):2249-56. PubMed ID: 17968322
[TBL] [Abstract][Full Text] [Related]
32. t(3;21)(q26;q22) with AML1 rearrangement in a de novo childhood acute monoblastic leukaemia.
Johansson B; Fioretos T; Garwicz S; Heim S; Mitelman F
Br J Haematol; 1996 Feb; 92(2):429-31. PubMed ID: 8603012
[TBL] [Abstract][Full Text] [Related]
33. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
34. Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia.
Hsiao HH; Sashida G; Kodama A; Fukutake K; Ohyashiki K
Cancer Genet Cytogenet; 2005 May; 159(1):96-7. PubMed ID: 15860366
[No Abstract] [Full Text] [Related]
35. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.
Nucifora G; Begy CR; Erickson P; Drabkin HA; Rowley JD
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7784-8. PubMed ID: 8395054
[TBL] [Abstract][Full Text] [Related]
36. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
Kurokawa M; Mitani K; Imai Y; Ogawa S; Yazaki Y; Hirai H
Blood; 1998 Dec; 92(11):4003-12. PubMed ID: 9834202
[TBL] [Abstract][Full Text] [Related]
37. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
38. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
Tanaka T; Mitani K; Kurokawa M; Ogawa S; Tanaka K; Nishida J; Yazaki Y; Shibata Y; Hirai H
Mol Cell Biol; 1995 May; 15(5):2383-92. PubMed ID: 7739522
[TBL] [Abstract][Full Text] [Related]
39. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
Martinelli G; Ottaviani E; Buonamici S; Isidori A; Borsaru G; Visani G; Piccaluga PP; Malagola M; Testoni N; Rondoni M; Nucifora G; Tura S; Baccarani M
Haematologica; 2003 Nov; 88(11):1221-8. PubMed ID: 14607750
[TBL] [Abstract][Full Text] [Related]
40. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
